Navigation Links
ACRES Announces Strategic Alliance with Atlantis Global Research Institute
Date:9/26/2013

Cambridge, Massachusetts (PRWEB) September 26, 2013

The Atlantis Global Research Institute (AGRI) today announced that it will work with the Alliance for Clinical Research Excellence and Safety (ACRES) to accelerate development of the ACRES Global Network, a group of high performing sites connected through a shared technology platform as part of an open and global system for clinical research. To that end, AGRI has joined ACRES as a Strategic Alliance partner and will immediately begin registering all of its global research sites in the ACRES network.    

AGRI Managing Director, Robert Wallace, noted, “We are elated to become an ACRES Alliance member and to have our national and international research sites join the ACRES global network. We believe that medical innovation and progress come from the formation of synergistic partnerships that enable conduct of clinical trials globally through a centralized process and, most importantly, provide access to novel treatment options to patients across the globe. Our alliance with ACRES allows this vision to become a reality.”

AGRI has developed a proprietary structure that allows the bio-pharmaceutical, pharmaceutical, device and diagnostic industry to conduct their clinical trials in a more time and cost-efficient manner. AGRI’s methodology is propelling the clinical trial industry forward by reducing the overall time and costs involved with conducting clinical trials.

Founded in 2012 AGRI has already established itself as one of the fastest growing and most innovative global research institutes worldwide, with over 100 research sites across the globe.

“Like ACRES, AGRI is a young and rapidly growing organization, and we share a new vision for the future of clinical research,” said ACRES President and CEO, Dr. Greg Koski. “We are delighted that AGRI is among the first global clinical research organizations to partner with ACRES to begin building a truly global system of research sites dedicated to enhancing excellence and safety in clinical trials world-wide for the benefit of all.”

About ACRES

ACRES, a global non-profit organization based in Cambridge, Massachusetts, is working in the public interest to build a comprehensive, sustainable and shareable global system for clinical research. By bringing together experts, stakeholders and like-minded organizations, ACRES is creating and implementing systems solutions that will enhance safety, data quality and integrity in an efficient, collaborative and cost effective manner to improve the health and lives of people everywhere.

About AGRI

Atlantis Global Research Institute (AGRI) is pioneering changes in how global clinical research is conducted by developing synergistic partnerships, collaborations, and alliances to produce quality results in a more timely and cost-efficient manner.

Read the full story at http://www.prweb.com/releases/GregKoskiACRES/biomedicalpharmaresearch/prweb11149403.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ACRES Launches Global Clinical Research Network Technology Platform
2. Pipette.com Announces Promotional T-Shirt and Other Specials for Neuroscience 2013
3. Cato Research Announces New Hires of Strategic Business Development Personnel
4. Gentris Corporation Partners with BioFortis, Announces New Vice President of Information Technology
5. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
6. Senomyx Announces Management Update
7. DTRA/SCC-WMD Announces $1 Million Algorithm Challenge Winner
8. Thermax Inc. Announces Price Increase on Ion Exchange Resins
9. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
10. Harwood Feffer LLP Announces Investigation of Verenium Corporation
11. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... it is exhibiting in booth 513 at the Association of Community Cancer Centers ... Hotel, March 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations ...
(Date:3/29/2017)... and NEWARK, Del. , March ... privately-held regenerative medicine company, and W. L. Gore ... company, today announced a collaborative research agreement whereby the ... cell therapy delivery device technologies that provide protection from ... decade, ViaCyte has been developing innovative stem cell-derived cell ...
(Date:3/29/2017)... 29, 2017 Research and Markets has ... and Global Markets" report to their offering. ... The study ... sequencing, biochips, RNA interference, synthetic biology tools and genome editing ... These technologies and products are analyzed to determine ...
Breaking Biology Technology:
(Date:3/6/2017)... , March 6, 2017 ... sales technology, today announced Predictive Sales Coach TM ... infusing actionable sales intelligence into Salesforce. This unique ... enable their sales organizations with deep knowledge of ... allow for intelligent engagement. Predictive Sales Coach extends ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
Breaking Biology News(10 mins):